• Viral 'molecular scissor' is next COVID-19 drug target

    4 days ago - By ScienceDaily

    Inhibiting the SARS-CoV-2-PLpro enzyme is a novel avenue to explore in rational design of COVID-19 drugs, according to new research.
    Read more ...


  • Lipid management options expand with novel drugs, new targets

    4 days ago - By Healio

    Management of lipids and residual cardiovascular risk has been a growing concern in endocrinology, and new data in this area are encouraging.
    Much emphasis has been placed on the use of therapies such as PCSK9 inhibitors, statins and ezetimibe to achieve target LDL levels. However, controlling LDL does not always control CVD risk, and because some patients are not able to achieve LDL and other targets on existing therapies, new options are needed.
    “In the last 5 years, there has been a lot of change in lipidology,” Savitha Subramanian, MD, associate professor in the division of
    Read more ...